AICAR

AICAR — 5-Aminoimidazole-4-carboxamide ribonucleotide — is a small nucleotide molecule that mimics AMP, the cell's universal 'low energy' signal. It is one of the most-studied AMPK activators in metabolic research and is often nicknamed an 'exercise mimetic' because it activates many of the same downstream pathways triggered by sustained physical exercise. It is not a peptide in the strict sense, but it is grouped with research peptides because of its overlapping uses in metabolic, endurance, and longevity research. It is sold for laboratory use only and is banned by WADA in competitive sport.

When your cells run low on energy — say, during a long run — they release a signal that turns on a master switch called AMPK. AMPK is the cellular equivalent of 'we're working hard now, start burning fuel efficiently.' AICAR is a research compound that flips that switch directly, without you having to do the workout first. In rodent studies, sedentary mice given AICAR ran significantly farther than untreated controls — the experiment that earned AICAR its 'exercise in a bottle' nickname in headlines worldwide.

AICAR enters cells and is phosphorylated to ZMP, which mimics AMP and activates AMP-activated protein kinase (AMPK). Activated AMPK shifts metabolism toward catabolic, energy-producing pathways: increased fatty acid oxidation, increased glucose uptake, mitochondrial biogenesis via PGC-1α, and suppression of energy-consuming processes like protein and cholesterol synthesis. The net effect mirrors the metabolic adaptations of endurance training.

• •Endurance and exercise mimetic studies
• •Type 2 diabetes and insulin sensitivity
• •Mitochondrial biogenesis and PGC-1α signaling
• •Cardioprotection in ischemia-reperfusion models
• •Cancer metabolism research
• •WADA doping detection methodology

AICAR's internet fame began with the 2008 Salk Institute mouse studies showing dramatic endurance improvements. Bodybuilding and endurance forums lit up overnight, and WADA banned it shortly after. Today, online discussion focuses on its theoretical fat-loss and metabolic benefits, frequent comparisons with MOTS-c (another mitochondrial-focused compound), and acknowledgment that human data lags far behind the mouse hype. It is expensive, has a short half-life, and is poorly absorbed — practical realities forum users often overlook.

“A workout, in a vial.”

AICAR is most often discussed alongside MOTS-c and 5-Amino-1MQ in metabolic and longevity stacks. In endurance-focused forums, it is paired with GW501516 (cardarine) — a separate SARM-adjacent compound that targets PPAR-delta. Both AICAR and GW501516 are banned by WADA, which limits any legitimate competitive use.

AICAR is an AMPK-activating nucleotide analog studied as an exercise mimetic, with strong rodent data on endurance, mitochondrial biogenesis, and metabolic health. It is banned in competitive sport, sold for laboratory research only, and limited human safety data exists.